| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |